2024 Q3 Form 10-Q Financial Statement
#000168316824005366 Filed on August 08, 2024
Income Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
Revenue | $100.6M | $90.38M |
YoY Change | 9.23% | 6.51% |
Cost Of Revenue | $50.06M | $46.71M |
YoY Change | 32.07% | 30.82% |
Gross Profit | $45.02M | $43.67M |
YoY Change | -6.59% | -11.15% |
Gross Profit Margin | 44.76% | 48.32% |
Selling, General & Admin | $19.00M | $36.99M |
YoY Change | 3.4% | 12.31% |
% of Gross Profit | 42.2% | 84.69% |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $214.0K | $221.0K |
YoY Change | 7.54% | 4.74% |
% of Gross Profit | 0.48% | 0.51% |
Operating Expenses | $93.73M | $42.50M |
YoY Change | 20.38% | 39.12% |
Operating Profit | -$48.71M | $1.172M |
YoY Change | 64.21% | -93.7% |
Interest Expense | $50.06M | $5.500M |
YoY Change | 32.11% | |
% of Operating Profit | 469.28% | |
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | $6.851M | $6.672M |
YoY Change | -51.81% | -64.14% |
Income Tax | $2.055M | $2.000M |
% Of Pretax Income | 30.0% | 29.98% |
Net Earnings | $4.796M | $4.672M |
YoY Change | -53.79% | -66.52% |
Net Earnings / Revenue | 4.77% | 5.17% |
Basic Earnings Per Share | $0.22 | $0.22 |
Diluted Earnings Per Share | $0.20 | $0.19 |
COMMON SHARES | ||
Basic Shares Outstanding | 21.33M shares | 21.02M shares |
Diluted Shares Outstanding | 24.15M shares | 24.26M shares |
Balance Sheet
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $8.071M | $9.752M |
YoY Change | -2.76% | 37.72% |
Cash & Equivalents | $8.071M | $9.752M |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | $7.788M | $12.03M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $15.86M | $21.78M |
YoY Change | -62.77% | -59.24% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $1.078M | $1.192M |
YoY Change | -16.76% | -7.17% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $40.90M | $259.3M |
YoY Change | 57.96% | 66.81% |
Total Long-Term Assets | $3.447B | $3.265B |
YoY Change | 21.44% | 16.58% |
TOTAL ASSETS | ||
Total Short-Term Assets | $15.86M | $21.78M |
Total Long-Term Assets | $3.447B | $3.265B |
Total Assets | $3.463B | $3.287B |
YoY Change | 20.2% | 15.16% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $49.68M | $66.39M |
YoY Change | -14.34% | 15.7% |
Accrued Expenses | $22.60M | $23.23M |
YoY Change | 438.12% | 340.71% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $72.28M | $66.39M |
YoY Change | 16.21% | 15.7% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $3.105B | $2.940B |
YoY Change | 21.65% | 15.68% |
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $3.105B | $2.940B |
YoY Change | 21.65% | 15.68% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $72.28M | $66.39M |
Total Long-Term Liabilities | $3.105B | $2.940B |
Total Liabilities | $3.178B | $3.006B |
YoY Change | 21.52% | 15.68% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $261.9M | $257.1M |
YoY Change | 8.83% | 11.65% |
Common Stock | $25.04M | $25.06M |
YoY Change | -11.37% | -10.29% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $285.1M | $280.3M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $3.463B | $3.287B |
YoY Change | 20.2% | 15.16% |
Cashflow Statement
Concept | 2024 Q3 | 2024 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $4.796M | $4.672M |
YoY Change | -53.79% | -66.52% |
Depreciation, Depletion And Amortization | $214.0K | $221.0K |
YoY Change | 7.54% | 4.74% |
Cash From Operating Activities | $69.76M | $43.29M |
YoY Change | 13.99% | -22.03% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $100.0K | $145.0K |
YoY Change | -50.0% | 353.13% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$218.9M | -$209.0M |
YoY Change | 165.36% | 190.87% |
Cash From Investing Activities | -$219.0M | -$209.2M |
YoY Change | 164.83% | 190.94% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 161.7M | 281.5M |
YoY Change | 1848.16% | 11434.21% |
NET CHANGE | ||
Cash From Operating Activities | 69.76M | 43.29M |
Cash From Investing Activities | -219.0M | -209.2M |
Cash From Financing Activities | 161.7M | 281.5M |
Net Change In Cash | 12.44M | 115.7M |
YoY Change | -194.25% | -929.73% |
FREE CASH FLOW | ||
Cash From Operating Activities | $69.76M | $43.29M |
Capital Expenditures | $100.0K | $145.0K |
Free Cash Flow | $69.66M | $43.15M |
YoY Change | 14.2% | -22.24% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6487000 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5127000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
8125000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
6062000 | shares |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
29700000 | usd |
CY2024Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
26800000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
6200000 | usd | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
13300000 | usd | |
CY2024Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
2894000 | shares |
us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z9yjw1tyiei8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_860_zUFmCDJXmWFc">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: justify">Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on net income or shareholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> | ||
CY2024Q2 | us-gaap |
Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
|
12714000 | usd |
CY2023Q4 | us-gaap |
Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
|
27553000 | usd |
CY2024Q2 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
442000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
1100000 | usd |
CY2024Q2 | us-gaap |
Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
|
12714000 | usd |
CY2023Q4 | us-gaap |
Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
|
27553000 | usd |
CY2024Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
1890000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
14728000 | usd |
CY2023Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
2869000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
21753000 | usd |
CY2024Q2 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
-1950000 | usd |
CY2023Q2 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
-9700000 | usd |
us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
-3585000 | usd | |
us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
-18700000 | usd | |
CY2024Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
431000 | usd |
CY2023Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
1897000 | usd |
us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
1432000 | usd | |
us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
4914000 | usd | |
CY2024Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
1175000 | usd |
CY2023Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
2590000 | usd |
us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
2832000 | usd | |
us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
7582000 | usd | |
CY2024Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
684000 | usd |
CY2023Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
5721000 | usd |
CY2024Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
684000 | usd |
CY2023Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
5721000 | usd |
CY2024Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
431000 | usd |
CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
1897000 | usd |
us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
1432000 | usd | |
us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
4914000 | usd | |
CY2024Q2 | cpss |
Gross Balance Of Repossessions In Inventory
GrossBalanceOfRepossessionsInInventory
|
435000 | usd |
CY2023Q4 | cpss |
Gross Balance Of Repossessions In Inventory
GrossBalanceOfRepossessionsInInventory
|
597000 | usd |
us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
-371000 | usd | |
CY2023 | us-gaap |
Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
|
-472000 | usd |
CY2024Q2 | us-gaap |
Foreclosed Assets
ForeclosedAssets
|
64000 | usd |
CY2023Q4 | us-gaap |
Foreclosed Assets
ForeclosedAssets
|
125000 | usd |
cpss |
Final Scheduled Payment Date
FinalScheduledPaymentDate
|
– | ||
CY2024Q2 | cpss |
Receivables Pledged
ReceivablesPledged
|
3006726000 | usd |
CY2024Q2 | cpss |
Securitization Trust Debt Initial Principal
SecuritizationTrustDebtInitialPrincipal
|
6255048000 | usd |
CY2024Q2 | us-gaap |
Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
|
2753447000 | usd |
CY2023Q4 | us-gaap |
Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
|
2280021000 | usd |
CY2024Q2 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
17200000 | usd |
CY2023Q4 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
14600000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
256900000 | usd |
CY2024Q2 | us-gaap |
Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
|
206321000 | usd |
CY2023Q4 | us-gaap |
Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
|
301813000 | usd |
CY2024Q1 | cpss |
Securitization Of Residual Interests
SecuritizationOfResidualInterests
|
50000000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
|
50000000 | usd |
CY2024Q2 | cpss |
Securitization Of Residual Interests Outstanding
SecuritizationOfResidualInterestsOutstanding
|
50000000 | usd |
CY2024Q2 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
921000 | usd |
CY2023Q4 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
125000 | usd |
CY2024Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
1782000 | usd |
CY2023Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
4378000 | usd |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
4119000 | usd | |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
9040000 | usd | |
CY2024Q2 | us-gaap |
Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
|
85099000 | usd |
CY2023Q2 | us-gaap |
Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
|
76735000 | usd |
us-gaap |
Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
|
165604000 | usd | |
us-gaap |
Interest Income Purchased Receivables
InterestIncomePurchasedReceivables
|
150793000 | usd | |
CY2024Q2 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
1486000 | usd |
CY2023Q2 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
1524000 | usd |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
2932000 | usd | |
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
2866000 | usd | |
CY2024Q2 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
88367000 | usd |
CY2023Q2 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
82637000 | usd |
us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
172655000 | usd | |
us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
162699000 | usd | |
CY2024Q2 | us-gaap |
Interest Expense
InterestExpense
|
46710000 | usd |
CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
35706000 | usd |
us-gaap |
Interest Expense
InterestExpense
|
88678000 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
68465000 | usd | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21263000 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20866000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21203000 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20643000 | shares | |
CY2024Q2 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
3000000 | shares |
CY2023Q2 | us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
4507000 | shares |
us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
3230000 | shares | |
us-gaap |
Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
|
4741000 | shares | |
CY2024Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
24263000 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
25373000 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
24433000 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
25384000 | shares | |
CY2024Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1700000 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1700000 | shares | |
CY2023Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1500000 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1500000 | shares | |
CY2024Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
2400000 | usd |
CY2024Q2 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
2400000 | usd |
CY2024Q2 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
2000000 | usd |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
4000000 | usd | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.30 | pure | |
CY2023Q2 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
4700000 | usd |
us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
9300000 | usd | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.25 | pure | |
CY2023Q3 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
1100000 | usd |
CY2024Q2 | cpss |
Probable Legal Contingencies
ProbableLegalContingencies
|
2300000 | usd |
CY2024Q2 | cpss |
Maximum Possible Losses For Legal Proceedings And Contingencies
MaximumPossibleLossesForLegalProceedingsAndContingencies
|
4300000 | usd |
CY2024Q1 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2791373000 | usd |
CY2023Q1 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2575117000 | usd |
CY2023Q4 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2722662000 | usd |
CY2022Q4 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2476617000 | usd |
CY2024Q2 | us-gaap |
Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
|
424867000 | usd |
CY2023Q2 | us-gaap |
Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
|
305450000 | usd |
us-gaap |
Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
|
753760000 | usd | |
us-gaap |
Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
|
658048000 | usd | |
CY2024Q2 | cpss |
Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
|
-208964000 | usd |
CY2023Q2 | cpss |
Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
|
-215314000 | usd |
cpss |
Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
|
-419899000 | usd | |
cpss |
Payments On Finance Receivables At Fair Value
PaymentsOnFinanceReceivablesAtFairValue
|
-421940000 | usd | |
CY2024Q2 | cpss |
Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
|
52401000 | usd |
CY2023Q2 | cpss |
Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
|
46833000 | usd |
cpss |
Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
|
106648000 | usd | |
cpss |
Net Interest Income Accretion On Fair Value Receivables
NetInterestIncomeAccretionOnFairValueReceivables
|
94305000 | usd | |
CY2024Q2 | cpss |
Mark To Fair Value
MarkToFairValue
|
5500000 | usd |
CY2023Q2 | cpss |
Mark To Fair Value
MarkToFairValue
|
0 | usd |
cpss |
Mark To Fair Value
MarkToFairValue
|
10500000 | usd | |
cpss |
Mark To Fair Value
MarkToFairValue
|
0 | usd | |
CY2024Q2 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2960375000 | usd |
CY2023Q2 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2618420000 | usd |
CY2024Q2 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2960375000 | usd |
CY2023Q2 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2618420000 | usd |
CY2024Q2 | cpss |
Finance Receivables Contractual Balance
FinanceReceivablesContractualBalance
|
3160134000 | usd |
CY2024Q2 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2960375000 | usd |
CY2023Q4 | cpss |
Finance Receivables Contractual Balance
FinanceReceivablesContractualBalance
|
2941915000 | usd |
CY2023Q4 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2722662000 | usd |
CY2024Q2 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2960375000 | usd |
CY2023Q4 | us-gaap |
Receivables Fair Value Disclosure
ReceivablesFairValueDisclosure
|
2722662000 | usd |
cpss |
Discount Rate On Finance Receivables
DiscountRateOnFinanceReceivables
|
11.39% | ||
CY2023 | cpss |
Discount Rate On Finance Receivables
DiscountRateOnFinanceReceivables
|
11.35% | |
cpss |
Cumulative Net Losses On Finance Receivables
CumulativeNetLossesOnFinanceReceivables
|
15.38% | ||
CY2023 | cpss |
Cumulative Net Losses On Finance Receivables
CumulativeNetLossesOnFinanceReceivables
|
15.25% | |
CY2024Q2 | us-gaap |
Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
|
3160134000 | usd |
CY2023Q4 | us-gaap |
Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
|
2941915000 | usd |
CY2024Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
9752000 | usd |
CY2024Q2 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
256859000 | usd |
CY2024Q2 | cpss |
Finance Receivables Fair Value Disclosure
FinanceReceivablesFairValueDisclosure
|
10326000 | usd |
CY2024Q2 | us-gaap |
Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
|
129000 | usd |
CY2024Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
82175000 | usd |
CY2024Q2 | cpss |
Residuals Interest Financing
ResidualsInterestFinancing
|
99079000 | usd |
CY2024Q2 | us-gaap |
Accounts Payable Fair Value Disclosure
AccountsPayableFairValueDisclosure
|
8473000 | usd |
CY2024Q2 | us-gaap |
Secured Debt
SecuredDebt
|
2711060000 | usd |
CY2024Q2 | us-gaap |
Subordinated Debt
SubordinatedDebt
|
22356000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
6174000 | usd |
CY2023Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
119257000 | usd |
CY2023Q4 | cpss |
Finance Receivables Fair Value Disclosure
FinanceReceivablesFairValueDisclosure
|
20848000 | usd |
CY2023Q4 | us-gaap |
Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
|
292000 | usd |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
234025000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Fair Value Disclosure
AccountsPayableFairValueDisclosure
|
7928000 | usd |
CY2023Q4 | us-gaap |
Secured Debt
SecuredDebt
|
2183331000 | usd |
CY2023Q4 | us-gaap |
Subordinated Debt
SubordinatedDebt
|
17188000 | usd |
CY2024Q2 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q2 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q2 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |